Browsing by Author "Khamashta, Munther"

Now showing items 1-3 of 3

    • Thumbnail

      Anti-Inflammatory and Immunosuppressive Drugs and Reproduction 

      Ostensen, Monika; Khamashta, Munther; Lockshin, Michael; Parke, Ann; Brucato, Antonio; Carp, Howard; Doria, Andrea; Rai, Raj; Meroni, Pierluigi; Cetin, Irene; Derksen, Ronald; Branch, Ware; Motta, Mario; Gordon, Caroline; Ruiz Irastorza, Guillermo; Spinillo, Arsenio; Friedman, Deborah; Cimaz, Rolando; Czeizel, Andrew; Piette, Charles Piette; Cervera, Ricard; Levy, Roger A.; Clementi, Maurizio; De Carolis, Sara; Petri, Michelle; Shoenfeld, Yehuda; Faden, David; Valesini, Guido; Tincani, Angela (Biomed Central, 2006-05-11)
      Rheumatic diseases in women of childbearing years may necessitate drug treatment during a pregnancy, to control maternal disease activity and to ensure a successful pregnancy outcome. This survey is based on a consensus ...
    • Thumbnail

      Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study 

      Ferreira, Isabel; Croca, Sara; Raimondo, Maria Gabriella; Matharu, Manjit; Miller, Sarah; Giles, Ian; Isenberg, David; Ioannou, Yiannis; Hanly, John G.; Urowitz, Murray B.; Anderson, Nicole; Aranow, Cynthia; Askanase, Anca; Bae, Sang-Cheol; Bernatsky, Sasha; Bruce, Ian N.; Buyon, Jill; Clarke, Ann E.; Dooley, Mary Anne; Fortin, Paul R.; Ginzler, Ellen; Gladman, Dafna; Gordon, Caroline; Inanc, Murat; Jacobsen, Soren; Kalunian, Kenneth; Kamen, Diane; Khamashta, Munther; Lim, Sam; Manzi, Susan; Merrill, Joan; Nived, Ola; Peschken, Christine; Petri, Michelle; Ramsey Goldman, Rosalind; Ruiz Irastorza, Guillermo; Sanchez-Guerrero, Jorge; Steinson, Kristjan; Sturfelt, Gunnar K.; Van Vollenhoven, Ronald; Wallace, Daniel J.; Zoma, Asad; Rahman, Anisur (Biomed Central, 2017-12-22)
      Background: In patients with systemic lupus erythematosus (SLE) there is no serological test that will reliably distinguish neuropsychiatric (NP) events due to active SLE from those due to other causes. Previously we showed ...
    • Thumbnail

      Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus 

      Enocsson, Helena; Wirestam, Lina; Dahle, Charlotte; Padyukov, Leonid; Jonsen, Andreas; Urowitz, Murray B; Gladman, Dafna D; Romero Díaz, Juanita; Bae, Sang Cheol; Fortin, Paul R.; Sánchez Guerrero, Jorge; Clarke, Ann E; Bernatsky, Sasha; Gordon, Caroline; Hanly, John G; Wallace, Daniel J.; Isenberg, David A; Rahman, Anisur; Merrill, Joan T; Ginzler, Ellen; Alarcón, Graciela S; Chatham, W Winn; Petri, Michelle; Khamashta, Munther; Aranow, Cynthia; Mackay, Meggan; Dooley, Mary Anne; Manzi, Susan; Ramsey Goldman, Rosalind; Nived, Ola; Steinsson, Kristjan; Zoma, Asad A; Ruiz Irastorza, Guillermo; Lim, S Sam; Kalunian, Kenneth C; Inanc, Murat; van Vollenhoven, Ronald F; Ramos Casals, Manuel; Kamen, Diane L; Jacobsen, Soren; Peschken, Christine A; Askanase, Anca; Stoll, Thomas; Bruce, Ian N; Wettero, Jonas; Sjowall, Christopher (Elsevier, 2019-10-17)
      OBJECTIVE: The soluble urokinase plasminogen activator receptor (suPAR) has potential as a prognosis and severity biomarker in several inflammatory and infectious diseases. In a previous cross-sectional study, suPAR levels ...